The WHO approved clinical trials for two Ebola vaccines during a DRC outbreak
The WHO approved clinical trials for two new vaccines targeting the Bundibugyo strain of Ebola, amid the DRC’s largest-ever outbreak. More than 5,300 people have been killed since May, most in the DRC. The African Centres for Disease Control and Prevention said 10,444 cases had been confirmed. Kenya reported nine cases, including two deaths; WHO confirmed one case in Nigeria.
More context
The World Health Organization has approved clinical trials for two new vaccines designed to fight the Bundibugyo strain of Ebola, as health workers try to control the Democratic Republic of the Congo’s largest-ever outbreak. On Monday, WHO expert groups recommended adding the two trials. The Bundibugyo strain has killed more than 5,300 people since May, most of them in the DRC, according to Al Jazeera. A tally by the African Centres for Disease Control and Prevention put confirmed cases at 10,444, making this the fastest-growing outbreak in DRC history. Kenya has reported nine cases, including two deaths, while the WHO has confirmed one case in Nigeria.
Was this story useful?
What was the main problem? (optional)
Reporting
Verifier’s note
Al Jazeera reports that the Bundibugyo outbreak has killed more than 5,300 people, most in the DRC, matching the proposed claim. The other results concern vaccines or separate Ebola-related developments.